Interview: Fachmi Idris – President Director, BPJS Kesehatan (Social Security Administering Body for Health), Indonesia

10.07.2017
Prof. Dr. dr. Fachmi Idris, M.Kes, president director at BPJS Kesehatan explains the evolution of the Universal Healthcare coverage program of Indonesia (JKN-KIS), the challenges inherent in its implementation, and the Indonesian government’s commitment to overcoming them. Dr. Fachmi, can you briefly introduce the main activities and responsibilities of BPJS Kesehatan?
"The main purpose of BPJS Kesehatan is the successful and sustainable implementation of the Universal Healthcare coverage program of Indonesia (JKN-KIS)"
Become a PharmaBoardroom Member for free to access this content
Join the 20,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Register
Already a member? Sign In
Tags:
Indonesia, BPJS Kesehatan, JKN, Healthcare, Regulatory Reform,

Related Interviews

Interview: Evie Yulin – Country Director, Merck Biopharma Indonesia

Evie Yulin, biopharma country director at Merck Indonesia, speaks towards the meaning of innovation in emerging countries and how the company engages in innovation beyond products. Since 2012, Merck has been…

Interview: Marlia Hayati Goestam – President Director & Joey Romana…

Marlia Hayati and Joey Romana, President Director and Vice President Director at PT Darya-Varia Laboratoria, share insights about the company’s strong brand equity and pioneering manufacturing strategy. In 2016, the…

Interview: Haris Izmee – Director, GE Healthcare Indonesia

Haris Izmee, director at GE Healthcare Indonesia, explains the strong commitment of the company towards improving access, affordability and quality and highlights the company’s significant investments in internal capabilities and…

Related Articles

Indonesia / National Pharma Champion Optimistic of COVID-Related Growth

With a market value of USD 5.2 billion, Kalbe Farma has consolidated into Indonesia’s undisputed national pharma champion and has established a footprint in many ASEAN countries as well as…

Southeast Asia / Kalbe Underwhelms in Indonesia; Novavax Looks to Filipino Vaccine Manufacturing; Thai Cannabis Market Boom

The latest from the pharma industry in Southeast Asia, including underwhelming results from Kalbe Pharma, Indonesia’s largest pharma company; Novavax’s vaccine manufacturing plans in the Philippines; the promising future of…

APAC / Prestige & HH&L IPO News; Cold Chain Vaccine Challenges; Moderna Looks to CMOs

The latest pharma news from the Asia-Pacific region, including upcoming IPOs for Prestige Biopharma and HH&L Acquisition; logistics challenges for COVID-19 vaccine distributors; and Moderna’s CMO-based vaccine manufacturing strategy in…

Latest Report

InFigures Asia-Pacific 2021

Related Content

Indonesia
BPJS Kesehatan
JKN
Healthcare
Regulatory Reform